Sage Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022
04 January 2022 - 10:30PM
Business Wire
Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical
company committed to developing novel therapies with the potential
to transform the lives of people with debilitating disorders of the
brain, announced today that the Company will present at the 40th
Annual J.P. Morgan Healthcare Conference on Tuesday, January 11,
2022 at 7:30am ET.
A live webcast of the presentation can be accessed on the
Investor page of Sage’s website at investor.sagerx.com. A replay of
the webcast will also be archived for up to 30 days on Sage's
website following the conference.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company committed to
developing novel therapies with the potential to transform the
lives of people with debilitating disorders of the brain. We are
pursuing new pathways with the goal of improving brain health, and
our depression, neurology and neuropsychiatry franchise programs
aim to change how brain disorders are thought about and treated.
Our mission is to make medicines that matter so people can get
better, sooner. For more information, please visit
www.sagerx.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220103005480/en/
Investor Contact Helen Rubinstein 315-382-3979
Helen.Rubinstein@sagerx.com
Media Contact Maureen L. Suda 617-949-4289
Maureen.Suda@sagerx.com
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Sep 2024 to Oct 2024
Sage Therapeutics (NASDAQ:SAGE)
Historical Stock Chart
From Oct 2023 to Oct 2024